Advisory Board and Editors Immunology
Altijana Hromić-Jahjefendić
Dr. Altijana Hromić-Jahjefendić is an associate professor at the Genetics and Bioengineering Department at International University of Sarajevo, Bosnia and Herzegovina. She obtained her bachelor's degree in chemistry and master's degree in Biochemistry and Molecular Biomedicine at Graz University of Technology, Austria. After that she worked for Austrian Center of Industrial Biotechnology and continued to pursue her PhD degree in Biochemistry and Molecular Biomedicine with the focus on Structural biology. Since 2018. she works as professor at International University of Sarajevo at the Genetics and Bioengineering Department. She authored many scientific publications with international colleagues in the field of COVID-19 and cancer research.
Md Asiful Islam
Dr Asiful is currently working as a research fellow at the WHO Collaborating Centre for Global Women’s Health, Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, UK.
Dr Md Asiful Islam completed his PhD (Fast Track, Passed with Grade 1, Pass without correction) in Genetics & Autoimmunity from Human Genome Centre, Universiti Sains Malaysia (November 2018) under Professor Dr Siew Hua Gan following completing BSc in Biochemistry & Molecular Biology (Jahangirnagar University, Dhaka, Bangladesh). He achieved Malaysia International Scholarship and USM Vice-Chancellor Award during his PhD and working as a Senior Lecturer at the Department of Haematology, School of Medical Sciences, Universiti Sains Malaysia from 2019 till 2022.
Besides PeerJ, he has been working as an Academic Editor for Nature Scientific Data, PLOS ONE, BMC Rheumatology, Autoimmunity Highlights, Endocrine, Metabolic & Immune Disorders - Drug Targets, Current Immunology Reviews and Current Rheumatology Reviews.
Dr Asiful's research interest covers different research areas of Medical Sciences including Haematology, Immunology, Pharmacology, Molecular Genetics and Neurosciences. He is currently focused on developing and executing systematic reviews and meta-analyses decoding various research questions of Medical Sciences.
Christopher J. Jolly
Head of the DNA Repair Group, Centenary Institute, Sydney, Australia
Postdoctoral Fellow, MRC Laboratory of Molecular Biology, Cambridge, UK
Postdoctoral Fellow, John Curtin School of Medical Research, ANU, Canberra
PhD, Macquarie University/CSIRO, Sydney
Christine Josenhans
Christine Josenhans is Professor for Microbiology and Medical Microbiology at Max von Pettenkofer Institute of Ludwig Maximilians University Munich and an infectious disease specialist. Until 2017, she was Associate Professor at Hannover Medical School, Germany, also in the field of infection research and molecular and cellular microbiology. Her research foci are on infectious disease agents in general, with specialization in microbiology, biochemistry, immunology, and host-pathogen interactions. She performed her Post-doctoral studies on Yersinia host-pathogen interactions, more specifically on their type III secretion system pore proteins. Current research foci are in persistent bacterial and viral infections, host-pathogen crosstalk and immune interference, as well as in the causal link between infections and cancer.
She is on the board of several undergraduate and graduate teaching programs.
Lawrence P. Kane
Professor of Immunology and Vice Chair for Education, University of Pittsburgh School of Medicine. Currently serving as a standing member of NIH/CSR study section CMI-A. Past Section Editor of the Journal of Immunology. Currently an associate editor at F1000 Research, Frontiers in Immunology and PeerJ, as well as an Faculty member of F1000 Prime Immunology.
Kathleen A Kelly
Kathleen Kelly is a Professor who joined the Department of Pathlogy and Lab Medicine in 1999. Dr. Kelly earned her B.S. in Medical Technology and PhD in Immunology at the Ohio State University in Columbus, Ohio. She was a postdoctoral fellow at Washington University in St. Louis, where she worked on the role of T cell subsets in germinal center formation. She then served as a junior faculty member in the Department of Microbiology and Immunology at the University of Arkansas for Medical Sciences. She focused on mucosal immunology and concentrated her studies on immune responses in the reproductive tract.
Dr. Kelly is actively involved in graduate, undergraduate and medical student education. She is a recipient of the Young Scientist Award and past chair of the Immunology Division for the American Society of Microbiology.
Haseeb A. Khan
Distinguished Professor of Biochemistry at College of Science, King Saud University, Riyadh, Saudi Arabia. Group Leader of Analytical and Molecular Bioscience Research Group and a Chair Professor at Research Chair for Biomedical Applications of Nanomaterials, King Saud University. PhD from Aligarh Muslim University, Aligarh, India and received scientific trainings in USA, UK, Denmark and Finland. Fellow of the Royal College of Pathologists (FRCPath) and the Royal Society of Chemistry (FRSC), UK. Authored more than 300 publications including 2 books and 20 book chapters. Recipient of Microsoft eScience Award. Listed in Top-2% World Ranking of Scientists. Research interests are clinical biochemistry, analytical chemistry, environmental chemistry, nanobiotechnology, molecular conservation, bioinformatics, pharmacology, and toxicology.
Theerapong Krajaejun
Professor of Clinical Pathology, Department of Pathology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Ziad Kronfol
Ziad Kronfol, M.D. is Professor of Psychiatry and Psychiatry Clerkship Director at Weill Cornell Medicine – Qatar. He previously was Associate Professor of Psychiatry and Director of the Psychoneuroimmunology Program at the University of Michigan in Ann Arbor. Dr. Kronfol is past Vice-President of the Asian Federation of Psychiatric Associations, Distinguished Life Fellow of the American Psychiatric Association and member of the section on education in the World Psychiatric Association.
Hang Fai Kwok
Prof Kwok’s research interests mainly focus on the development of novel monoclonal antibodies and venom-based peptides as prototype drugs for anticancer and anti-inflammatory therapies. In addition, Prof. Kwok’s research group is also expanding scientific knowledge and research in the areas of existing and novel cancer biomarkers such as 1) matricellular protein — OPN, 2) metalloproteinase — ADAM17 & ADAMTS5, 3) DNA replication licensing factor — MCM proteins, 4) small GTP binding protein — RAN, as well as immunotherapy markers (e.g. PD-1/PD-L1) in order to identify and validate their prognostic and therapeutic values according to the roles in hallmarks of cancer.
Julia Kzhyshkowska
1997: PhD Cancer Research Centre of the Russian Academy of Medical Sciences, Moscow.
1997-2001: Postdoc at the University of Regensburg
2001-2007: Junior group leader/PI and lecturer, University of Heidelberg.
2007- 2010:Senior group leader/PI and senior lecturer, University of Heidelberg
2010-2013: Professor, head of the Lab for Cellular and Molecular Biology of Innate Immunity;
2013-permanent: Professor, head of Department for Innate Immunity and Tolerance, University of Heidelberg.
Nicole L La Gruta
Prof La Gruta's research focuses on understanding the key determinants of effective antiviral CD8+ T cell responses, both with respect to magnitude and TCR usage. She is also interested in how thymic selection influences the composition of naive epitope-specific T cell populations and how aging impacts intrinsic CD8+ T cell function.